CERo Therapeutics
OTC: CEROSan Francisco, US · Founded 2016 · Delaware corporation
Founders & leadership
CERo Therapeutics was founded in 2016 by Daniel Mark Corey.
DM
Daniel Mark CoreyFounder
LC
Lawrence CoreyExecutive
JT
Jordan Thomas CoreyExecutive
Reported raises · per SEC filings
Form D private placements$44.6M disclosed across 2 rounds · 2017–2019
▶$43.2MraisedNov 2019 · 31 investors · OtherRule 506(b)
▶$43.2MraisedNov 2019 · 31 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Stan RiddellDirector
- Heather TurnerDirector
- Daniel Mark CoreyExecutive Officer, Director, Promoter
- Stuart SloanDirector
- Lawrence CoreyExecutive Officer, Promoter
- Jordan CoreyExecutive Officer, Promoter
- Offering amount
- $43.2M
- Amount sold
- $43.2M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$1.4MraisedMar 2017 · 7 investors · OtherRule 506(b)
▶$1.4MraisedMar 2017 · 7 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Lawrence CoreyExecutive Officer, Director
- Jordan Thomas CoreyExecutive Officer
- Daniel Mark CoreyDirector
- Offering amount
- $2.5M
- Amount sold
- $1.4M
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded CERo Therapeutics?
- CERo Therapeutics was founded by Daniel Mark Corey in 2016.
- How much funding has CERo Therapeutics raised?
- CERo Therapeutics has disclosed $44.6M raised across 2 rounds.
- Where is CERo Therapeutics headquartered?
- CERo Therapeutics is headquartered in San Francisco, US.